How to Value a Medicaid-Heavy Medical Practice in 2026

Medicaid-heavy medical practices are the most misunderstood segment of healthcare M&A. Sellers expect multiples that look like commercial or even Medicare practices and are disappointed. Buyers assume there's no business there at all and walk past real opportunities. The truth is that Medicaid practices — and the FQHC and look-alike entities that share their patient base — have their own valuation logic driven by reimbursement dynamics, federal grant streams, 340B pharmacy economics, and managed Medicaid contracting. If you understand the mechanics, there's real value. If you don't, you'll either undersell or overpay.

The Two Very Different Businesses Under the Medicaid Label

Before you can value a Medicaid practice, you have to identify which kind you're looking at, because they trade at completely different multiples.

Private practice with heavy Medicaid mix. A physician-owned practice — pediatrics, OB/GYN, primary care, behavioral health — where 60-90% of visits are billed to state Medicaid fee schedules or managed Medicaid plans (Centene, Molina, Elevance, UnitedHealthcare Community Plan). These practices trade at 0.2-0.6x collections or 2.0-3.5x EBITDA, and the buyer pool is narrow: regional health systems, behavioral health consolidators, and occasionally specialty PE platforms targeting pediatric dental/medical combos.

FQHC or FQHC look-alike. Federally Qualified Health Centers operate under Section 330 grants from HRSA. They're non-profit 501(c)(3) entities, so they don't sell in the traditional sense — but they merge, they acquire private practices, and their wholly-owned subsidiaries (MSOs, real estate entities, ancillary businesses) do change hands. FQHCs receive cost-based reimbursement under the PPS (Prospective Payment System), which typically pays 2-4x what a private Medicaid practice earns for the same visit. That changes everything.

If your practice is technically private but operates under an FQHC contract, an RHC (Rural Health Clinic) designation, or a CCBHC (Certified Community Behavioral Health Clinic) certification, the economics look much closer to an FQHC than a pure private Medicaid practice.

Why Private Medicaid Practices Trade at a Discount

Reimbursement rates are brutal. State Medicaid fee schedules typically pay 40-60% of Medicare rates, and Medicare already pays less than commercial. A 99213 office visit that commercial pays $115 and Medicare pays $85 might pay $48 under Texas Medicaid or $38 under Mississippi Medicaid. The unit economics simply don't support high multiples.

State budget risk. Every time a state legislature faces a budget shortfall, Medicaid rates get cut or freeze. Buyers build that risk into their underwriting. A practice in a state that just cut pediatric Medicaid rates 4% will get priced 10-15% below the same practice in a state that just raised rates.

Volume dependency. Because per-visit revenue is so low, Medicaid practices only work at high volume. A pediatric practice running 40+ patients per provider per day can be genuinely profitable; a practice running 22 patients per day with the same overhead is underwater. Buyers are pricing a high-volume operating model, and if the physician isn't willing or able to maintain that pace, the model falls apart.

No-show rates. Medicaid patient populations typically run 15-25% no-show rates compared to 5-8% for commercial. That's lost capacity that doesn't come back, and it structurally reduces the EBITDA margin that any buyer can underwrite.

Where the Value Actually Hides

Managed Medicaid contracts with value-based terms. Just like Medicare Advantage, managed Medicaid plans (Centene, Molina, Anthem, UHC) are increasingly shifting primary care and behavioral health to capitated or shared-savings arrangements. A pediatric practice with 4,000 managed Medicaid members under a capitated contract at $45 PMPM is generating $2.16M of predictable annual revenue independent of visit volume. Buyers will pay meaningfully higher multiples for that than for straight fee-for-service Medicaid practices.

CCBHC and SUD certifications. Certified Community Behavioral Health Clinics get PPS-rate reimbursement (cost-based, like FQHCs) for behavioral health visits. A private behavioral health practice that holds CCBHC status trades at something like 1.5-3x revenue or 6-9x EBITDA, which is 3-5x the multiple of a non-CCBHC Medicaid behavioral health practice. The certification is hard to get and impossible to quickly reproduce, which is exactly why it carries a premium.

340B pharmacy revenue. If your practice is eligible for 340B drug pricing (through an FQHC affiliation, look-alike status, or other covered entity designation), the pharmacy spread is often the single biggest source of profit in the whole operation. I've seen Medicaid-focused practices where the 340B contract pharmacy arrangement generates more EBITDA than the entire clinical practice. Buyers underwrite that stream separately and often apply higher multiples to it.

Real estate. Medicaid practices often own their buildings, especially in underserved markets where health systems couldn't justify the capital. The real estate is sometimes worth more than the practice itself, and a sale-leaseback prior to the clinical operations sale can be the cleanest way to extract value.

FQHC Dynamics: The Mission-Driven Premium

FQHCs aren't for-profit entities and don't have traditional shareholders, but they do transact. Here's where private practice owners get confused: an FQHC can acquire your private Medicaid practice, and when it does, the acquiring FQHC benefits from cost-based PPS reimbursement on your volume. That means the same book of visits that's worth $200K/year to you under fee-for-service Medicaid is worth $600-$800K/year to the FQHC under PPS.

What this means practically: if your private Medicaid practice is located in or near an FQHC service area, the FQHC may be the best buyer in the market even though FQHCs are not known for paying aggressive multiples. They can justify a higher price because the asset is worth more in their hands. I've seen private pediatric practices sell to FQHCs for 0.8-1.2x collections when the same practice would have fetched 0.3x from a health system.

Federal and State Grant Revenue

Grant revenue is tricky to value. HRSA Section 330 grants, SAMHSA block grants, state opioid response grants, CCBHC expansion grants, and maternal/child health grants can represent 10-40% of an FQHC or CCBHC's revenue base. Buyers treat grant revenue with skepticism because it's non-recurring in any contractual sense — it's appropriated year to year, subject to federal budget priorities, and often tied to specific program deliverables.

The right way to think about it: strip grant revenue out of EBITDA for multiple purposes, value the underlying clinical operations at the appropriate multiple, and then add back a discounted present value of the grant stream — typically 1-3 years of grant revenue at a heavy discount. Never apply a standard EBITDA multiple to blended clinical + grant income, because you'll overvalue the business and trigger a diligence implosion.

Who Actually Buys These Practices

• Regional health systems: motivated by Medicaid DSH payments, community benefit requirements, and downstream referral capture. Multiples are modest (0.4-0.7x) but deal certainty is high.
• Behavioral health consolidators: Discovery Behavioral Health, Acadia Healthcare, and PE-backed platforms pay solid multiples for Medicaid behavioral health practices with CCBHC status or strong managed Medicaid contracts.
• FQHCs: cost-based reimbursement economics let them pay more than the practice is worth under private billing.
• Pediatric platforms: a handful of PE-backed pediatric groups (Pediatrix is the public comp, plus several private platforms) will buy Medicaid-heavy pediatric practices as part of broader geographic strategies.

What to Fix Before Selling

Maximize your managed Medicaid contracting. If you're not in-network with the dominant managed Medicaid plans in your state, fix that 12-18 months before sale. If value-based contracts are available, pursue them.

Document your volume discipline. Buyers will want to see that you're running at the volume the model requires. Clean scheduling data, no-show tracking, and provider productivity reports are essential.

Clean up your compliance posture. Medicaid audits are aggressive. Any open or unresolved audit findings will scare buyers. Work with a healthcare compliance attorney to clean these up before going to market.

Separate real estate from operations. If you own the building, consider whether a sale-leaseback or a separate real estate sale generates more total value than bundling it with the practice. See the broader practice prep guide for sequencing.

Explore certifications. If you qualify for RHC, CCBHC, or FQHC look-alike status, pursuing the designation can meaningfully increase your eventual sale value — though it takes 18-36 months to complete. See our multiples by industry reference for how these compare.

The Bottom Line

Medicaid-heavy practices don't trade like commercial or cash-pay practices and they shouldn't. The reimbursement math is fundamentally different, the buyer pool is narrower, and the value drivers are specific to the regulatory structure. But within that reality, there are real opportunities to capture value — through managed Medicaid contracts, behavioral health certifications, 340B economics, and FQHC-adjacent buyers who can justify paying more because the asset is worth more in their hands. The sellers who do best in this segment are the ones who understand which buyer universe they're selling into and build the practice to fit it.